Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Baxter
McKinsey
AstraZeneca
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for UNASYN at ClinicalTrialExchange

DrugPatentWatch Database Preview

UNASYN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Unasyn, and when can generic versions of Unasyn launch?

Unasyn is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in UNASYN is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.

Summary for UNASYN
Drug patent expirations by year for UNASYN
Drug Prices for UNASYN

See drug prices for UNASYN

Recent Clinical Trials for UNASYN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center, HoustonPhase 1
Mercy Health OhioPhase 4
Pfizer

See all UNASYN clinical trials

US Patents and Regulatory Information for UNASYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 062901-002 Feb 27, 1992 AP RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 050608-001 Dec 31, 1986 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 062901-001 Nov 23, 1988 AP RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 050608-002 Dec 31, 1986 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 050608-003 Dec 31, 1986 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer UNASYN ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 050608-005 Dec 10, 1993 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Medtronic
Mallinckrodt
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.